Jul 21, 2021

80-year-old grandmother suffers rare blood disorder after COVID vaccine

Grandma blood disorder COVID jab

Maureen Deboick received the first dose of her vaccine on March 24, and two weeks later developed a headache. A fortnight later, a rash of black blisters formed inside her mouth.

The woman went to Albany Hospital and was then flown to Perth, spending 17 days in Fiona Stanley Hospital.

Deboick was diagnosed with immune thrombocytopenia (ITP), a rare bleeding disorder that has been assessed as carrying a one-in-100,000 chance of developing after the AstraZeneca vaccine.

Deboick told 9News she does not want to deter Australians from getting vaccinated, but she said it was important the community is aware of potential side effects.

“They say it is a one-in-100,000 chance … but that one in 100,000 is going to suffer,” Deboick said.

Health experts have emphasised that Ms Deboick’s case is rare. There have been more than 5.4 million AstraZeneca vaccines administered in Australia, and only 31 suspected cases of ITP.

“We have to look back to the UK where it is the primary vaccine and is actually the most common variety of vaccine used in the world,” he added. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Contact tracing for aged care workers

During the COVID-19 pandemic, contact tracing has become an essential tool to prevent the spread of the virus, particularly in workplaces such as aged care where support staff can come into close contact with seniors who are vulnerable to infection. Read More

“We found more than 54,000 viruses in people’s poo – and 92% were previously unknown to science”

Everybody poos (but not all poo is the same). It’s fair to say the human gut is now the most well-studied microbial ecosystem on the planet. Yet more than 70% of the microbial species that live there have yet to be grown in the laboratory. Read More

Would A New Combined COVID/Flu Vaccine Benefit Public Health?

There have been positive results in phase 3 of a clinical trial of a combined vaccine against COVID and influenza. So what sort of impact would a two-in-one COVID and flu vaccine have on public health? Read More
Advertisement